Welcome
Support Centre
13 May 2008 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

Submit your study protocol
[ Print-friendly version ]
Effect of tempe and vitamin C rich fruit supplementation during pregnancy on iron status and pregnancy outcomes
ISRCTN ISRCTN13994081
ClinicalTrials.gov identifier
Public title Effect of tempe and vitamin C rich fruit supplementation during pregnancy on iron status and pregnancy outcomes
Scientific title
Acronym N/A
Serial number at source N/A
Study hypothesis Does food-based intervention using tempe and vitamin C rich fruit during pregnancy improve the iron status?
Ethics approval Ethical Committee for Studies on Human Subjects, Faculty of Medicine, University of Indonesia. Date of approval: 19/02/2007 (ref: 49/PTO2.FK/ETIK/2007)
Study design Randomised controlled single-centre trial (unit of randomisation: village).
Countries of recruitment Indonesia
Disease/condition/study domain Anaemia during pregnancy
Participants - inclusion criteria 1. Pregnant women, gestation 12-20 weeks
2. Age 15-49 years
3. No existing severe maternal illness
Participants - exclusion criteria 1. Suffer from chronic disease
2. In medication/antibiotic treatment
3. Do not sign inform consent
Anticipated start date 01/11/2007
Anticipated end date 01/11/2008
Status of trial Ongoing
Patient information material
Target number of participants 250
Interventions The participating villages will be randomly allocated to the following two groups:

Supplementary group will receive supplementary food, 400 mg albendazole, and health and nutrition
education. The average weekly supplementary food consist of: 600 g tempe (fermented soybean), 30 g red meat/dried anchovy/chicken liver, 45 g soy sauce, 350 g guava, 300 g papaya and 100 g orange. Supplementary food will be given daily at 12-20 week of gestation until delivery at home.

Control group will receive 400 mg albendazole only.
Primary outcome measure(s) Maternal iron status at gestation 12-20 week:
1. Haemoglobin
2. Ferritin
3. Soluble transferrin receptors
Secondary outcome measure(s) 1. Infectious status at gestation 12-20 weeks and 32-36 weeks:
1.1. C-reactive protein
1.2. A-1 acid glycoprotein
2. Helminth infestation (hookworms, A.lumbricoides, T.trichiura) measured quantitatively (eggs per gram) at gestation 12-20 weeks and 32-36 weeks
3. Gestational age calculated from date of last menstruation and palpation
4. Weight gain of pregnant women and birth weight of infant will be measured with electronic weighing scale
5. Length of infant will be measured with length board
6. Complication deliveries/fetal loss will be measured with verbal autopsy interviews, less than 3 days after delivery
Sources of funding Nestle Foundation (Switzerland)
Trial website
Publications
Contact name Mrs  Maria  Wijaya-Erhardt
  Address Seameo-Tropmed RCCN-UI
Jl. Salemba Raya 6
  City/town Jakarta
  Zip/Postcode 10430
  Country Indonesia
  Tel +62 21 3914017
  Fax +62 21 3914017
  Email mwijaya@seameo-rccn.org
Sponsor Nestle Foundation (Switzerland)
  Address 4, Place de la Gare
PO BOX 581
  City/town Lausanne
  Zip/Postcode 1001
  Country Switzerland
  Tel +41 21 320 33 51
  Fax +41 21 320 33 92
  Email nf@nestlefoundation.org
  Sponsor website: http://www.nestlefoundation.org
Date applied 06/09/2007
Last edited 08/04/2008
Date ISRCTN assigned 08/04/2008
News
28 Sept 2007: 2007 Update of NHS Trusts Clinical Trials Register now available online
Aug 2007: Searches on ISRCTN register can now be bookmarked
Jul 2007: Patient information material field added to the ISRCTN Register
May 2007: WHO launches the International Clinical Trials Registry Search Portal
3 Apr 2007: Q&As regarding trial registration in the UK
4 Dec 2006: Trials taking place in the UK collated in 'Gateway'

© ISRCTN


BioMed Central